Clinical Trial: A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07090655) titled 'A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers' on July 21.

Brief Summary: The main objective is to assess the safety and tolerability of subcutaneous and intravenous injection forms of budoprutug in healthy volunteers.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: Budoprutug

Subcutaneous or IV administration

DRUG: Placebo

Placebo comparator

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Climb Bio, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....